What is the Trident Lifeline Ltd share price today?

The share price of BSE:TLL-M on 01 Oct 2026 (as of 15:07:03 IST) is ₹374.9.

What is the BSE:TLL-M 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:TLL-M 52 week high low range shows a high of ₹421 and a low of ₹229.95.

What is the Trident Lifeline Ltd market cap?

As on 01 Oct 2026, Trident Lifeline Ltd market cap is ₹4376860000.

What is the shareholding pattern of Trident Lifeline Ltd Stock?

The shareholding pattern of Trident Lifeline Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 62.59% Foreign Institutional Investors (FII): 5.25% Domestic Institutional Investors (DII): 0.26% Mutual Funds: 0% Retail & Others: 31.9% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Trident Lifeline Ltd?

The Price-to-Earnings (PE) ratio of Trident Lifeline Ltd is 22.9865, and the Price-to-Book (PB) ratio is 4.7803, as on 01 Oct 2026.

Trident Lifeline Share Price

417.00+0.00 (+0.00%)

+40.64% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.00%

1 Week

+1.98%

1 Month

+7.17%

3 Month

+63.85%

6 Month

+52.25%

YTD

+34.21%

1 Year

+40.64%

5 Year

10 Year

Max

+297.14%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

417.00

385.10

367.55

254.00

240.00

229.95

High

417.00

420.00

442.00

About

Trident Lifeline Limited is engaged in the pharmaceutical business ethical marketing in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

TLL-MNSE

LTP

1W Low

1W High

Market cap (₹)

1784.6+6.35 (0.36%)

1720.80

1796.45

4,25,150Cr

9995.5+280.5 (2.89%)

9866.35

10080.20

2,66,265Cr

4638.6+3.45 (0.07%)

4555

4665.10

1,76,301Cr

2314-78 (-3.26%)

2252.50

2442

1,25,352Cr

1256.3+12.3 (0.99%)

1217.70

1264.20

1,23,591Cr

1371.65+21.45 (1.59%)

1337.30

1390.70

1,14,351Cr

1395+15 (1.09%)

1364.75

1400.60

1,12,474Cr

2486.05-2.7 (-0.11%)

2457.35

2523.70

1,02,315Cr

1695.85+18.05 (1.08%)

1656.90

1707.60

97,757Cr

2022.55+13.55 (0.67%)

1989.10

2061.55

92,007Cr

417+8.1 (1.98%)

385.10

420

500Cr

Trident Lifeline Share Price

417.00+0.00 (+0.00%)

+40.64% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years60%

Last year48%

Compounded Profit Growth

10 years-

5 years-

3 years47%

Last year84%

Stock Price CAGR

10 years-

5 years-

3 years30%

1 year41%

Return on Equity

10 years33%

5 years33%

3 years19%

Last year25%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	60%	48%
-	-	47%	84%
-	-	30%	41%
33%	33%	19%	25%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

TLL-M

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,784.6	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
9,995.5	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,638.6	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,314	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,256.3	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,371.65	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,395	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,486.05	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,695.85	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,022.55	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
417	₹500 Cr	26.24	5.52	20.96	₹19 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Dec 2025	Sep 2025	Jun 2025	Dec 2024	Sep 2024	Jun 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Jun 2022	Mar 2022
₹47 Cr	₹34 Cr	₹26 Cr	₹31 Cr	₹24 Cr	₹12 Cr	₹15 Cr	₹13 Cr	₹7 Cr	₹5 Cr	₹9 Cr	₹8 Cr	₹9 Cr	₹6 Cr	₹9 Cr
₹97 L	₹57 L	₹5 Cr	₹2 Cr	₹1 Cr	₹56 L	₹54 L	₹1 Cr	₹25 L	₹38 L	₹33 L	₹64 L	₹39 L	₹90,000	₹17 L
₹48 Cr	₹34 Cr	₹30 Cr	₹33 Cr	₹25 Cr	₹12 Cr	₹16 Cr	₹14 Cr	₹7 Cr	₹5 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹6 Cr	₹9 Cr
₹37 Cr	₹27 Cr	₹23 Cr	₹25 Cr	₹20 Cr	₹8 Cr	₹12 Cr	₹11 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹7 Cr
₹12 Cr	₹9 Cr	₹10 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹2 Cr	₹43 L	₹2 Cr	₹3 Cr	₹2 Cr	₹87 L	₹2 Cr
₹2 Cr	₹86 L	₹1 Cr	₹99 L	₹1 Cr	₹55 L	₹50 L	₹49 L	₹15 L	₹9 L	₹10 L	₹15 L	₹13 L	₹8 L	₹7 L
₹9 Cr	₹7 Cr	₹6 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹1 Cr	₹28 L	₹2 Cr	₹2 Cr	₹2 Cr	₹70 L	₹2 Cr
₹7 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹62 L	₹1 Cr	₹2 Cr	₹2 Cr	₹70 L	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—	—
₹12 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹8 Cr
₹4 Cr	₹0	₹99 L	₹0	₹0
₹85 Cr	₹53 Cr	₹40 Cr	₹34 Cr	-₹3 Cr
₹85 Cr	₹53 Cr	₹40 Cr	₹34 Cr	-₹3 Cr
₹100 Cr	₹64 Cr	₹53 Cr	₹46 Cr	₹5 Cr
₹7 Cr	₹5 Cr	₹1 Cr	₹1 Cr	₹0
₹24 Cr	₹19 Cr	₹9 Cr	₹3 Cr	₹0
₹16 Cr	₹13 Cr	₹4 Cr	₹1 Cr	₹1 Cr
-₹2 Cr	-₹2 Cr	-₹15 L	-₹52 L	-₹1 Cr
₹7 L	₹7 L	₹7 L	₹7 L	₹7 L
₹38 Cr	₹30 Cr	₹13 Cr	₹3 Cr	₹45 L
—	—	—	—	—
₹38 Cr	₹15 Cr	₹8 Cr	₹5 Cr	₹5 Cr
₹16 Cr	₹19 Cr	₹7 Cr	₹4 Cr	₹1 Cr
₹26 Cr	₹17 Cr	₹4 Cr	₹3 Cr	₹60 L
₹8 Cr	₹5 Cr	₹2 Cr	₹57 L	₹51 L
₹88 Cr	₹55 Cr	₹21 Cr	₹12 Cr	₹8 Cr
₹234 Cr	₹155 Cr	₹88 Cr	₹62 Cr	₹13 Cr
₹5 Cr	₹5 Cr	₹0	₹0	₹0
₹73 Cr	₹54 Cr	₹18 Cr	₹8 Cr	₹2 Cr
—	—	—	—	—
₹78 Cr	₹57 Cr	₹23 Cr	₹4 Cr	₹2 Cr
₹18 Cr	₹14 Cr	₹2 Cr	₹1 Cr	₹80 L
₹61 Cr	₹44 Cr	₹21 Cr	₹3 Cr	₹1 Cr
₹17 Cr	₹2 Cr	₹4 Cr	₹5 Cr	₹0
₹8 Cr	₹11 Cr	₹4 Cr	₹3 Cr	₹0
₹8 Cr	₹11 Cr	₹4 Cr	₹3 Cr	₹0
₹2 Cr	₹1 Cr	₹4 Cr	₹85 L	₹67 L
₹3 Cr	₹3 Cr	₹0	₹0	₹0
₹91 Cr	₹61 Cr	₹33 Cr	₹12 Cr	₹2 Cr
—	—	—	—	—
₹2 L	₹0	₹0	₹0	₹0
₹36 Cr	₹28 Cr	₹13 Cr	₹7 Cr	₹4 Cr
₹74 Cr	₹28 Cr	₹13 Cr	₹12 Cr	₹5 Cr
₹4 Cr	₹2 Cr	₹7 Cr	₹14 Cr	₹16 L
₹1 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹9 L
₹24 Cr	₹32 Cr	₹18 Cr	₹14 Cr	₹2 Cr
₹140 Cr	₹92 Cr	₹53 Cr	₹50 Cr	₹11 Cr
₹52 Cr	₹37 Cr	₹32 Cr	₹38 Cr	₹3 Cr
₹3 Cr	₹3 Cr	₹2 Cr	₹67 L	₹3 L
₹234 Cr	₹155 Cr	₹88 Cr	₹62 Cr	₹13 Cr
₹79	₹54	₹43	₹39	₹6
₹79	₹54	₹43	₹39	₹6

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent of Subsidiaries under liquidations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
₹27 Cr	₹14 Cr	₹9 Cr	₹7 Cr	₹3 Cr
₹7 Cr	₹7 Cr	₹12 L	₹8 L	₹33 L
-₹22 Cr	-₹20 Cr	-₹4 Cr	-₹25 Cr	-₹4 Cr
₹13 Cr	₹56 L	₹5 Cr	-₹18 Cr	-₹36 L
₹5 Cr	-₹4 Cr	₹2 Cr	-₹19 Cr	-₹21 L
-₹37 Cr	-₹14 Cr	-₹20 Cr	-₹10 Cr	-₹45 L
₹34 Cr	₹14 Cr	₹11 Cr	₹42 Cr	₹80 L
₹2 Cr	-₹4 Cr	-₹7 Cr	₹14 Cr	₹14 L
₹2 Cr	₹7 Cr	₹14 Cr	₹18 L	₹1 L
₹0	₹11 L	₹0	₹0	₹0
₹4 Cr	₹2 Cr	₹7 Cr	₹14 Cr	₹16 L

Fundamental Ratios

Consolidated

Standalone

No results found

Trident Lifeline Share Price

417.00+0.00 (+0.00%)

+40.64% past 1 Year

Shareholding summary

Promoters

62.46%

FII

1.16%

DII

0.21%

Others

36.17%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
62.46%	62.59%	62.85%	64.11%	63.11%	63.04%
1.16%	5.25%	7.24%	7.04%	7.71%	7.21%
0.21%	0.26%	0.27%	0.35%	0.41%	0.39%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
36.17%	31.90%	29.64%	28.50%	28.77%	29.36%

Bulk & block deals

Name

Quarks Technosoft Private Limited

Craft Emerging Market Fund Pcc-Elite Capital Fund

Nav Capital Vcc - Nav Capital Emerging Star Fund

Rinkal Mayurbhai Gajera

Kamal Amar Shah

Prabhat Financial Services Limited

Brimming Wealth Advisors Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
15 Sep 2026	Purchase	2.40 Cr	₹289.34	82.80 K	Bulk	0.701814	BSE
15 Sep 2026	Sell	3.57 L	₹297.10	1.20 K	Bulk	0.010171	BSE
15 Sep 2026	Sell	2.26 Cr	₹283.74	79.80 K	Bulk	0.676386	BSE
15 Sep 2026	Sell	2.10 Cr	₹280.51	75 K	Bulk	0.635701	BSE
27 Mar 2026	Sell	1.58 Cr	₹263.40	60 K	Bulk	0.508561	BSE
27 Mar 2026	Purchase	2.48 Cr	₹261.46	94.80 K	Bulk	0.803526	BSE
23 Jan 2026	Sell	2.12 Cr	₹289.68	73.20 K	Bulk	0.620444	BSE
23 Jan 2026	Purchase	2.26 Cr	₹289.76	78 K	Bulk	0.661129	BSE

Insider trading & SAST

Client name

Hardik Desai Family Trust

Shikha Bafna

Hardik Desai Family Trust

Shikha Ashish Bafna

Hardik Desai Family Trust

Rinkal Mayurbhai Gajera

Rupaben Jariwala

Amit Halvawala

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
14 Jul 2026	Promoter	Acquisition	0.01	7.18	0	—	1.20 K	12 Jun 2026	Market	8,57,366	SAST	29(2)	—
14 Jul 2026	Other	Acquisition	0.02	0.23	0	—	3 K	03 Jun 2026	Market	27,600	SAST	29(1)	—
14 Jul 2026	Promoter	Acquisition	0.08	7.15	0	—	9 K	29 May 2026	Market	8,53,166	SAST	29(2)	—
15 Jun 2026	Promoter Group	Acquisition	0.010171	7.18	2.99 L	₹249	1.20 K	12 Jun 2026	Market Purchase	8,57,366	Insider Trading	—	Equity Shares
04 Jun 2026	Immediate Relative	Acquisition	0.025428	0.23	7.44 L	₹248	3 K	02 Jun 2026	Market Purchase	27,600	Insider Trading	—	Equity Shares
01 Jun 2026	Promoter Group	Buy	0.076284	7.15	22.39 L	₹248.82	9 K	29 May 2026	Market Purchase	8,53,166	Insider Trading	—	Equity
26 May 2026	Promoter	Disposal	0.5	3.48	0	—	60 K	27 Mar 2026	Market	4,15,010	SAST	29(2)	—
26 May 2026	Promoter	Disposal	0.23	5.3	0	—	27.60 K	27 Mar 2026	Market	6,31,900	SAST	29(2)	—
26 May 2026	Promoter	Disposal	0.14	0.85	0	—	16.80 K	30 Mar 2026	Market	1,01,500	SAST	29(2)	—
26 May 2026	Promoter	Disposal	0.15	0.99	0	—	18 K	27 Mar 2026	Market	1,18,300	SAST	29(2)	—

Trident Lifeline Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Trident Lifeline Share Price

Trident Lifeline Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Trident Lifeline Share Price

Trident Lifeline Share Price

Oscillators

Moving averages

Trident Lifeline Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Trident Lifeline Share Price

Corporate Actions

Company details

Trident Lifeline Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Trident Lifeline Share Price

News

Trident Lifeline reports Profit after tax of 5.66 Crores, in the March 2026 quarter

Trident Lifeline informs about updates

Trident Lifeline informs about trading window closure

Trident Lifeline reports Profit after tax of 4.02 Crores, in the December 2025 quarter

Trident Lifeline rises on acquiring additional stake in Trident Mediquip

Trident Lifeline acquires additional stake in Trident Mediquip

Trident Lifeline informs about resignation of director

Trident Lifeline reports Profit after tax of 4.94 Crores, in the September 2025 quarter

Trident Lifeline informs about board meeting

Trident Lifeline - Quaterly Results

Trident Lifeline reports Profit after tax of 3.48 Crores, in the June 2025 quarter

Trident Lifeline - Quaterly Results

Trident Lifeline - Quaterly Results

Trident Lifeline informs about board meeting

Trident Lifeline informs about disclosure

Trident Lifeline informs about disclosure

Trident Lifeline informs about outcome of board meeting

Trident Lifeline informs about disclosure

Trident Lifeline informs about disclosure

Trident Lifeline informs about disclosure

Trident Lifeline Ltd Share Price Today

Trident Lifeline Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator